Quantum-Si, Inc. (QSI)
0.8031
+0.01
(+1.58%)
USD |
NASDAQ |
Aug 27, 16:00
0.8056
0.00 (0.00%)
After-Hours: 20:00
Quantum-Si EPS Diluted (Quarterly) : -0.108 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.108 |
| March 31, 2026 | -0.1001 |
| December 31, 2025 | -0.0842 |
| September 30, 2025 | -0.1708 |
| June 30, 2025 | -0.157 |
| March 31, 2025 | -0.1053 |
| December 31, 2024 | -0.2264 |
| September 30, 2024 | -0.1778 |
| June 30, 2024 | -0.1627 |
| March 31, 2024 | -0.1374 |
| December 31, 2023 | -0.1557 |
| September 30, 2023 | -0.1746 |
| June 30, 2023 | -0.1807 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.1683 |
| December 31, 2022 | -0.237 |
| September 30, 2022 | -0.2273 |
| June 30, 2022 | -0.2332 |
| March 31, 2022 | -0.2537 |
| December 31, 2021 | -0.2142 |
| September 30, 2021 | -0.1326 |
| June 30, 2021 | -3.052 |
| March 31, 2021 | -2.131 |
| December 31, 2020 | -1.775 |
| September 30, 2020 | -0.579 |
| June 30, 2020 | -1.532 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Champions Oncology, Inc. | -0.048 |
| Medpace Holdings, Inc. | 4.250 |
| Avantor, Inc. | 0.0563 |
| Personalis, Inc. | -0.3005 |
| Adaptive Biotechnologies Corp. | -0.2489 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.53M |
| Revenue (Quarterly) | 0.344M |
| Total Expenses (Quarterly) | 23.88M |
| Enterprise Value | 67.30M |
| Gross Profit Margin (Quarterly) | -298.8% |
| Profit Margin (Quarterly) | -6.84K% |
| Earnings Yield | -57.66% |
| Normalized Earnings Yield | -52.32 |